While characterization of lung lesions and staging of lung cancer with fluorine-18
fluorodeoxyglucose positron emission tomography (FDG-PET) is an established clinical …

Background: The detection of solitary pulmonary nodules (SPNs) that may potentially
develop into a malignant lesion is essential for early clinical interventions. However, grading …

In recent years, molecular imaging with [18 F] fluorodeoxyglucose− positron-emission
tomography,[18 F] FDG-PET, has become part of the standard of care in initial staging of …

Abstract BACKGROUND.[18F] Fluoro‐2‐deoxyglucose uptake on positron emission
tomography (FDG‐PET) has been frequently used for diagnosis and staging of lung cancer …

Background: Accurate staging is necessary to determine the appropriate therapy in patients
with lung cancer. Few studies have compared integrated fluorine-18 fluorodeoxyglucose …

The purpose of this study was investigate the role of 18F-2deoxyglucose positron emission
tomography (FDG-PET) in staging small cell lung cancer (SCLC), its efficacy for the …

Background Gallium 68 (68Ga)–labeled fibroblast-activation protein inhibitor (FAPI) has
recently been introduced as a promising tumor imaging agent. Purpose To compare 68Ga …

Purpose The objective of this study was to determine the accuracy of (early) response
measurements using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography …

[F18]-2-deoxy-2fluoro-d-glucose positron emission tomography (FDG-PET) is increasingly
used in the diagnosis and staging of lung cancer. Despite its positive performance …

PURPOSE: To compare the accuracies of whole-body 2-[fluorine 18] fluoro-2-deoxy-d-
glucose (FDG) positron emission tomography (PET) and conventional imaging (thoracic …